Navigation Links
Macugen drug for treating degenerative eye disease

The drug Macugen is found to be effective in treating wet age related macular degeneration disease which is a progressive disease// of the macula. Wet age related macular degeneration is caused due to a chronic degenerative disease of the macula region of the eye, macula is present in the retina which is responsible for proper eye sight.

The degenerative disease is caused by the growth of abnormal blood vessel beneath the macula which leads to severe bleeding and accumulation of fluid in retina leading to a condition called Choroidal neovascularization. The new drug Macugen, which is manufactured by Pfizer and OSI Pharmaceuticals, is found to be very effective in treating this degenerative disease by preserving the visual integrity of the macula, the drug is found to stop bleeding and accumulation of fluid in the retina and is found to be very effective than other treatment procedures offered to cure eye disease.


Page: 1

Related medicine news :

1. Eye Drug Macugen Shows Allergic Reactions
2. Gene Therapy shows promise in treating Hemophilia
3. Ketoconazole 2% more effective in treating Seborrheic Dermatitis
4. Diuretics are better for treating blood pressure problems than newer medicines
5. A ray of hope in treating blindness and other eye disorders
6. Child Friendly Zidovudine Preparation for treating HIV infection Approved By The FDA
7. Surgeons in India to Mend ‘Pakistani Hearts’ by treating 70 Childrn
8. Weight reduction by 5% may help in treating nonalcoholic fatty liver disease
9. Lower doses of oral contraceptives helpful in treating acne
10. Systemic Corticosteroid Therapy can be used for treating all types of Infectious Mononucleosis
11. Novel Actemra monotherapy in treating patients with early aggressive rheumatoid arthritis
Post Your Comments:

(Date:6/27/2016)... ... June 27, 2016 , ... ... professionals, announced today its affiliation with Tennessee Counseling Association. This new ... network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , ...
(Date:6/26/2016)... ... , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center ... Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This annual ... the world’s leading providers of cereal and other breakfast foods. Its residents often refer ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: